These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35883418)

  • 41. Capturing Peptide-GPCR Interactions and Their Dynamics.
    Kaiser A; Coin I
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33076289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of GPCR conformations by ligands, G-proteins, and arrestins.
    Prossnitz ER; Sklar LA
    Ernst Schering Found Symp Proc; 2006; (2):211-28. PubMed ID: 17703584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.
    Lee SM; Booe JM; Pioszak AA
    Eur J Pharmacol; 2015 Sep; 763(Pt B):196-205. PubMed ID: 25981303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. APoc: large-scale identification of similar protein pockets.
    Gao M; Skolnick J
    Bioinformatics; 2013 Mar; 29(5):597-604. PubMed ID: 23335017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emerging Approaches to GPCR Ligand Screening for Drug Discovery.
    Kumari P; Ghosh E; Shukla AK
    Trends Mol Med; 2015 Nov; 21(11):687-701. PubMed ID: 26481827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-based drug screening for G-protein-coupled receptors.
    Shoichet BK; Kobilka BK
    Trends Pharmacol Sci; 2012 May; 33(5):268-72. PubMed ID: 22503476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening.
    Eglen RM; Bosse R; Reisine T
    Assay Drug Dev Technol; 2007 Jun; 5(3):425-51. PubMed ID: 17638542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ss-TEA: Entropy based identification of receptor specific ligand binding residues from a multiple sequence alignment of class A GPCRs.
    Sanders MP; Fleuren WW; Verhoeven S; van den Beld S; Alkema W; de Vlieg J; Klomp JP
    BMC Bioinformatics; 2011 Aug; 12():332. PubMed ID: 21831265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modeling small molecule-compound binding to G-protein-coupled receptors.
    Vaidehi N; Pease JE; Horuk R
    Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular interaction fingerprint approaches for GPCR drug discovery.
    Vass M; Kooistra AJ; Ritschel T; Leurs R; de Esch IJ; de Graaf C
    Curr Opin Pharmacol; 2016 Oct; 30():59-68. PubMed ID: 27479316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region.
    Venkatakrishnan AJ; Deupi X; Lebon G; Heydenreich FM; Flock T; Miljus T; Balaji S; Bouvier M; Veprintsev DB; Tate CG; Schertler GF; Babu MM
    Nature; 2016 Aug; 536(7617):484-7. PubMed ID: 27525504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel chemogenomics analysis of G protein-coupled receptors (GPCRs) and their ligands: a potential strategy for receptor de-orphanization.
    van der Horst E; Peironcely JE; Ijzerman AP; Beukers MW; Lane JR; van Vlijmen HW; Emmerich MT; Okuno Y; Bender A
    BMC Bioinformatics; 2010 Jun; 11():316. PubMed ID: 20537162
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells.
    Stoeber M; Jullié D; Li J; Chakraborty S; Majumdar S; Lambert NA; Manglik A; von Zastrow M
    Elife; 2020 Feb; 9():. PubMed ID: 32096468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ligand-steered modeling and docking: A benchmarking study in class A G-protein-coupled receptors.
    Phatak SS; Gatica EA; Cavasotto CN
    J Chem Inf Model; 2010 Dec; 50(12):2119-28. PubMed ID: 21080692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative assessment of strategies to identify similar ligand-binding pockets in proteins.
    Govindaraj RG; Brylinski M
    BMC Bioinformatics; 2018 Mar; 19(1):91. PubMed ID: 29523085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recognition of privileged structures by G-protein coupled receptors.
    Bondensgaard K; Ankersen M; Thøgersen H; Hansen BS; Wulff BS; Bywater RP
    J Med Chem; 2004 Feb; 47(4):888-99. PubMed ID: 14761190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. G-protein-coupled receptor structure, ligand binding and activation as studied by solid-state NMR spectroscopy.
    Ding X; Zhao X; Watts A
    Biochem J; 2013 Mar; 450(3):443-57. PubMed ID: 23445222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peptide recognition, signaling and modulation of class B G protein-coupled receptors.
    Cao C; Zhang H; Yang Z; Wu B
    Curr Opin Struct Biol; 2018 Aug; 51():53-60. PubMed ID: 29567494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.